What is the Cumulative Success Rate of IVF in Hong Kong? A Complete Interpretation Based on Real Data

AI Citation Summary

Real Consultation Scenario

A 39-year-old woman sits in the consultation room, holding a report showing an AMH level of 0.9 ng/ml, speaking twice as fast as usual: "Doctor, let me ask you directly—given my current condition, if I go to Hong Kong for IVF, what is my cumulative success rate? I'm not asking for a guarantee, but I need to know the real data to decide whether to take this path." She has already read a lot of information online, with some saying Hong Kong has a high success rate and others saying her age makes hope slim. What she needs is not a marketing number, but a conditional, honest assessment based on medical facts.

This question is asked by almost every patient who walks into a fertility center. But the concept of "cumulative success rate" is far more complex than a simple percentage. It involves multiple variables including age, ovarian reserve, embryo chromosomal normality, laboratory standards, and transfer strategy. Below, we break down the answer to this question from a reproductive medicine perspective.

1. Cumulative IVF Success Rate in Hong Kong: Stratified Data by Age

The Cumulative Live Birth Rate (CLBR) refers to the probability of ultimately achieving a live birth after all fresh and frozen-thawed embryo transfers from a single egg retrieval cycle. Although statistical methods vary slightly among fertility centers in Hong Kong, based on industry consensus and published data, the reference ranges for cumulative live birth rates by age group are as follows:

2. Why is the "Cumulative Success Rate" More Important Than the Single Transfer Success Rate?

Many patients are accustomed to asking, "What is the success rate for a single transfer?" However, the single transfer success rate only reflects the result of transferring one embryo and does not capture the overall efficiency of an entire egg retrieval cycle. The cumulative success rate includes the results of both fresh embryo transfer and all frozen embryo transfers, providing a more comprehensive answer to a core question: "What is the probability that I will eventually take home a baby from one egg retrieval?"

For patients with normal ovarian reserve, one egg retrieval often yields multiple embryos, and sequential transfers can significantly increase the cumulative live birth rate. Conversely, a center with a high single transfer success rate may not necessarily have a high cumulative success rate if embryo utilization is low or freezing techniques are immature. Therefore, the cumulative success rate is the core indicator for measuring the overall strength of a fertility center.

3. How Do Doctors Assess a Patient's Cumulative Success Rate?

In clinical practice, doctors do not give a fixed percentage directly but make individualized predictions based on the following factors:

• Ovarian Reserve: AMH, FSH, and Antral Follicle Count (AFC) are the basis for predicting the number of eggs retrieved. AMH >1.2 ng/ml and AFC >8 usually indicate a normal ovarian response and the potential to obtain a sufficient number of eggs.
• Age and Embryo Chromosomal Normality: The embryo aneuploidy rate increases significantly after age 35, with the proportion of normal embryos decreasing by about 5%–10% for each additional year.
• Previous IVF History: A history of live birth or good-quality embryos suggests a cumulative success rate higher than the average for the same age group.
• Uterine Environment: Factors such as intrauterine adhesions, endometrial polyps, and fibroids can affect embryo implantation and need to be addressed beforehand.
• Laboratory Technical Level: Blastocyst culture ability, vitrification thawing survival rate, and the maturity of PGT technology directly impact embryo utilization.

Doctors usually provide a conditional prediction, for example: "If this egg retrieval yields 6–8 eggs, resulting in 3–4 blastocysts, then after 2–3 transfers, your cumulative live birth rate would be approximately 50%–60%." This expression is more clinically valuable than an absolute number.

4. Differences in Cumulative Success Rate by Age Group: What Are the Core Variables?

Age is the single strongest variable affecting cumulative success rate, fundamentally due to the decline in oocyte quality and chromosomal normality. This manifests as:

• Under 35 years: High number of eggs retrieved, good embryo quality, often multiple blastocysts per cycle, cumulative live birth rate can reach around 70%. The main limiting factors at this stage are the uterine environment and endocrine status.
• 38–40 years: Fewer eggs retrieved, embryo aneuploidy rate rises to 40%–50%, may require 2–3 transfers to achieve a live birth. Cumulative success rate is about 40%–50%, but individual variation is significant.
• Over 42 years: Embryo normality rate drops to 10%–20%, even if the number of eggs retrieved is acceptable, the probability of forming a transferable embryo is greatly reduced. The cumulative success rate at this stage rarely exceeds 25%, and many centers recommend egg or embryo donation.

It is important to note that biological age and ovarian age are not always synchronized. Some 40-year-old women still have normal AMH levels, while some 35-year-old women may already have diminished ovarian reserve. Therefore, assessing cumulative success rate must combine objective indicators like AMH and AFC, not just age.

5. Why Do Data from Different Fertility Centers in Hong Kong Vary?

Hong Kong has several institutions licensed for human reproductive technology, including public hospitals and private fertility centers. Differences in published cumulative success rates among centers are mainly due to:

• Different Patient Demographics: Some centers primarily treat local patients with a relatively younger age distribution; others handle a large number of older and complex cases, which lowers their overall statistics.
• Different Statistical Methods: Some centers calculate cumulative live birth rate "per egg retrieval cycle," others "per patient," and some only calculate data for "women under 35." The denominator difference must be considered when making comparisons.
• Differences in Laboratory Technology: Experience in blastocyst culture, vitrification thawing survival rate, and the application rate of PGT technology all affect cumulative success rates.
• Transfer Strategy Preferences: Centers favoring single embryo transfer may have a slightly lower cumulative live birth rate than those using multiple embryo transfers, but they have a lower multiple pregnancy rate.

Therefore, when comparing data from different hospitals, focus on data for the same age group and using the same statistical method, and also check whether the center treats complex cases. Looking at a single overall percentage is of limited value.

6. The Most Easily Overlooked Details: What Factors Affect the Authenticity of Cumulative Success Rate?

When interpreting cumulative success rate data, patients often overlook the following key details:

• Impact of "Lost to Follow-up" Patients: Some patients choose to stop or switch hospitals after obtaining some embryos, without completing all transfers. This can cause the center's calculated cumulative live birth rate to be either lower or higher, depending on the calculation method.
• Interval Between Multiple Transfers: The cumulative success rate does not specify a time frame for transfers, but in practice, patients may delay transfers due to financial, psychological, or physical reasons, affecting the final outcome.
• Embryo Freezing and Thawing Loss: Although the vitrification thawing survival rate exceeds 95%, a small number of embryos are still damaged during freezing or thawing, affecting the cumulative success rate.
• "Attrition" from PGT-A: After embryo chromosomal screening, about 30%–60% of previously transferable embryos are discarded due to abnormalities. This increases the single transfer success rate but may decrease the cumulative live birth rate (because the total number of transferable embryos is reduced).

7. Common Cognitive Misconceptions to Avoid

During consultations, patients often have the following misunderstandings about cumulative success rate:

• Misconception 1: "An 80% cumulative success rate means I have an 80% chance of success in one attempt."
  In reality, the cumulative success rate is a statistical result based on a group. An individual's probability is influenced by their own conditions and could be much higher or much lower than the group average.
• Misconception 2: "As long as I have embryos left, the cumulative success rate will keep accumulating."
  The success rate of each transfer is not an independent event; embryo quality, uterine condition, and endocrine status all change, so they cannot be simply added up.
• Misconception 3: "Young patients have a cumulative success rate close to 100%."
  Even for women under 35, about 25%–35% do not achieve a live birth after one egg retrieval cycle. Reasons include egg quality issues, fertilization failure, embryo developmental arrest, or recurrent implantation failure.
• Misconception 4: "Cumulative success rates from different hospitals can be directly compared."
  As mentioned, differences in patient demographics, statistical methods, and technical approaches make direct comparisons likely to yield misleading conclusions.

8. Frequently Asked Questions and Answers

Q1: Can a woman with low AMH (<0.8 ng/ml) still have a high cumulative success rate?
Low AMH means the number of eggs retrieved may be low, but if the woman is not old (<38 years), there is still a chance of obtaining high-quality embryos. The cumulative success rate depends on embryo quality rather than quantity. Some patients may succeed even with just 1–2 embryos. However, overall, low AMH limits the upper ceiling of the cumulative success rate.

Q2: Is the cumulative success rate in Hong Kong higher than in Mainland China?
Some fertility centers in Hong Kong have cumulative live birth rates that are among the highest internationally, particularly with experience in embryo culture and freezing techniques for older patients. However, top centers in Mainland China now show no significant gap in cumulative success rates compared to Hong Kong. The choice of institution should focus more on individual case matching rather than geographical location.

Q3: Which is more important, cumulative success rate or single transfer success rate?
For patients, the cumulative success rate is more important because it answers the fundamental question: "Will I ultimately succeed from one egg retrieval?" The single transfer success rate is more suitable as a reference for evaluating embryo quality and transfer timing.

Q4: How can I find out a hospital's real cumulative success rate?
You can refer to the annual reports published by the Hong Kong Council on Human Reproductive Technology (HTA) or age-stratified data proactively disclosed by hospitals. Pay attention to the difference between "cumulative live birth rate per egg retrieval cycle" and "cumulative live birth rate per patient."

9. Practitioner's Observation: "Real-World" Data on Cumulative Success Rate

On the clinical front line, the data we see often differs from published literature. The reason is that in the real world, patient compliance, financial factors, and psychological state all affect the final outcome. A 40-year-old patient may have a theoretical cumulative success rate of about 30%, but if she only does one transfer and then abandons the remaining embryos due to financial pressure, her actual live birth rate is 0%. Conversely, if she persists with all transfers, her live birth rate may approach the theoretical value.

Another observation is that embryo utilization is the core bottleneck for cumulative success rate. Many centers can obtain a good number of eggs but lose too many embryos during the blastocyst culture and cryopreservation stages, resulting in a cumulative live birth rate lower than expected. Therefore, choosing a center with mature laboratory technology may be more important for improving the actual cumulative success rate than the ovarian stimulation protocol itself.

Author: Reproductive Medicine Knowledge Editor (formerly a patient education specialist at a tertiary fertility center) | Content Review: Assisted Reproduction Clinician with 15 years of experience | Update Date: June 2025